64Cu-labeled panitumumab for PET imaging of EGFR plus non-small cell lung cancer: Subcutaneous and metastatic mouse models

被引：0
|
作者：
Wuest, Frank [1 ]
Sarrami, Nasim [1 ]
Wuest, Melinda [1 ]
Paiva, Igor [1 ]
Leier, Samantha [1 ]
Lavasanifar, Afsaneh [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
来源：
NUCLEAR MEDICINE AND BIOLOGY | 2023年 / 126卷
基金：
加拿大自然科学与工程研究理事会;
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P-169
引用
收藏
页码：S188 / S188
页数：1
相关论文
共 50 条
  • [31] Sitravatinib plus tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
    Zhou, Q.
    Yu, X.
    Gao, B.
    Ma, Z.
    Chu, Q.
    Huang, D.
    Zhao, J.
    Day, D.
    Body, A. L.
    Pan, H.
    Cui, J.
    Li, H.
    Sun, J.
    Zhang, J.
    Fei, C.
    Wu, Y-L.
    ANNALS OF ONCOLOGY, 2022, 33 : S1 - S2
  • [32] Metastatic Non-Small Cell Lung Cancer to the Small Bowel
    Levy, Sara
    Shroff, Sagar
    Qayed, Emad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S421 - S421
  • [33] ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer
    Ehlerding, Emily B.
    England, Christopher G.
    Majewski, Rebecca L.
    Valdovinos, Hector F.
    Jiang, Dawei
    Liu, Glenn
    McNeel, Douglas G.
    Nickles, Robert J.
    Cai, Weibo
    MOLECULAR PHARMACEUTICS, 2017, 14 (05) : 1782 - 1789
  • [34] A METHODOLOGY FOR ESTIMATING THE POPULATION OF ADVANCED OR METASTATIC EGFR M plus NON-SMALL CELL LUNG CANCER PATIENTS IN THE UK AND IRELAND
    Mildred, M.
    VALUE IN HEALTH, 2014, 17 (07) : A550 - A550
  • [35] Therapy of Metastatic Non-small Cell Lung Cancer
    Reinmuth, N.
    Groeschel, A.
    Schumann, C.
    Sebastian, M.
    Wiewrodt, R.
    Reck, M.
    PNEUMOLOGIE, 2016, 70 (09): : 567 - 578
  • [36] Immunotherapy of metastatic non-small cell lung cancer
    Sackmann, Sandra
    Ogundele, Samuel
    Ukena, Dieter
    PNEUMOLOGE, 2019, 16 (06): : 353 - 365
  • [37] A FLEXIBLE OPEN-SOURCE COST-EFFECTIVENESS MODEL FOR METASTATIC EGFR plus NON-SMALL CELL LUNG CANCER
    Jansen, J. P.
    Incerti, D.
    Shafrin, J.
    Frederickson, A. M.
    Lakdawalla, D. N.
    Reckamp, K. L.
    VALUE IN HEALTH, 2018, 21 : S42 - S43
  • [38] Chemotherapy for metastatic non-small cell lung cancer
    Pérol, M
    Moro-Sibilot, D
    REVUE DES MALADIES RESPIRATOIRES, 2005, 22 (06) : S131 - S136
  • [39] Third generation EGFR TKI landscape for metastatic EGFR mutant non-small cell lung cancer (NSCLC)
    Tan, Aaron C.
    Teh, Yi Lin
    Lai, Gillianne G. Y.
    Tan, Daniel S. W.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (06) : 431 - 435
  • [40] Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
    Felip, Enriqueta
    Metro, Giulio
    Soo, Ross A.
    Wolf, Juergen
    Solomon, Benjamin J.
    Tan, Daniel S. W.
    Ardizzoni, Andrea
    Lee, Dae Ho
    Sequist, Lecia V.
    Barlesi, Fabrice
    Ponce-Aix, Santiago
    Abreu, Delvys Rodriguez
    Campelo, Maria Rosario Garcia
    Sprauten, Mette
    Djentuh, Leslie O'Sullivan
    Smith, Nathalie
    Jary, Aline
    Belli, Riccardo
    Glaser, Sabine
    Zou, Mike
    Cui, Xiaoming
    Giovannini, Monica
    Yang, James Chih-Hsin
    EUROPEAN JOURNAL OF CANCER, 2024, 208
12345